Submit your application for research grant funding
The AST is now accepting applications for 2015 research grants, including a new AST Transplant Nursing Grant. For 2015, the AST has identified research priorities in the areas of basic science, clinical science, and translational science. See the list of research priorities, See the list of research priorities, or click here to get started on your application. All applications are due by Monday, Sept. 15.
Save the Date for the AST 2014 Fellows Symposium, Sept. 19-21, in Grapevine, Texas
Any young professional starting a career in transplantation or immunology should attend this highly popular meeting. The AST Fellows Symposium features an in-depth and interactive study of clinical transplantation, basic transplant immunobiology and translational science in an informal setting, while providing important insights into career development and exceptional access to expert faculty.
Travel grants are available!
A limited number of travel grants are available for clinical and research fellows, and residents and trainees with an interest in solid organ transplantation.
Watch for registration opening in the coming weeks at www.myAST.org/fellows.
Now accepting abstracts!
ESOT + AST
Partnering to bring you the best transplantation science
Personalized Transplantation: From New Diagnostics to New Therapeutics
Submit your clinical, translational and basic abstracts on Novel Immune Monitoring and/or Diagnostics and Immunosuppression Strategies. Submission Deadline: Sunday, June 29
The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
Upcoming free webinars and webinars on demand
The following webinars and journal club are scheduled for June; all are free to AST members and are available on demand after the live air date.
AST also offers popular webinars and journal clubs on demand at www.myAST.org/T3, www.myAST.org/content/fellows-live-webinar-series, and www.myAST.org/journalclub.
- Fellows Webinar on Malignancies after SOT, Wed., June 4; register online
- Business of Transplantation Webinar on OPO Quality Programs, Wed., June 11; register online
- Journal Club on "A committed precursor to innate lymphoid cells", Tues., June 24, register online
RSVP for the AST Town Hall Meeting & Excellence in Transplantation Reception at the 2014 WTC
AST members are invited to take part in the annual member’s business meeting, delivered in an exciting interactive town hall format. The Town Hall will take place during the upcoming World Transplant Congress (WTC) on Tuesday, July 29, 2014 at 5:45 PM on the 2nd floor foyer of the Moscone West Convention Center. Join your colleagues and AST leadership to discuss the challenges and opportunities in the field of transplantation, learn how AST is positioned to meet these challenges/opportunities, and provide your feedback in shaping the future of the AST.
Immediately following the town hall, enjoy a casual gathering at the AST Excellence in Transplantation Reception, also on the 2nd floor foyer of the Moscone West Convention Center. Indulge in delectable libations and hors d’oeuvres as you mingle with friends, award and grant recipients, and supporters.
Please submit your R.S.V.P. to attend both the town hall and reception here. Should you have any questions, please do not hesitate to contact the AST staff at info@myAST.org or (856) 439-9986.
We look forward to seeing you in San Francisco!
These events made possible in part by Sanofi and Veloxis Pharmaceuticals.
Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible?
Annals of Surgical Oncology
Hepatocellular carcinoma (HCC) is one of the most common neoplasms. Curative treatment options include liver resection (LR) and transplantation (LT). Organ shortage leads to discussion whether resectable HCC in cirrhosis should undergo LT or LR. ... A low quality of evidence data suggests the following: resectable HCC should primarily be resected as good alternative to liver transplantation in patients in whom both seem feasible.
Sixth INTERMACS annual report: A 10,000-patient database
The Journal of Heart and Lung Transplantation (login required)
The sixth annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 8 years of patient enrollment. The analysis is based on data from less than 10,000 patients and updates demographics, survival, adverse events and risk factors. Among patients with continuous-flow pumps, actuarial survival continues to be 80 percent at one year and 70 percent at two years. The report features a comparison of two eras of continuous-flow durable devices in the USA in terms of device strategy, patient profiles, adverse event burden, survival and quality of life.
Missed last week's issue? See which articles your colleagues read most.
Single-center experience with extracorporeal photopheresis in pediatric heart transplantation
The Journal of Heart and Lung Transplantation (login required)
The pediatric heart transplant literature contains little information regarding extracorporeal photopheresis (ECP), despite International Society for Heart and Lung Transplantation guidelines recommending it for recurrent/recalcitrant rejection. We report our experience with ECP in pediatric heart transplantation.
Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation
Journal of the American Society of Nephrology
Canadian patients receiving intensive home hemodialysis (IHHD; ≥16 hours per week) have survival comparable to that of deceased donor kidney transplant recipients in the United States, but a comparison with Canadian kidney transplant recipients has not been conducted. We conducted a retrospective cohort study of consecutive, adult IHHD patients and kidney transplant recipients between 2000 and 2011 at a large Canadian tertiary care center.